Renal Denervation Market: Product, Technology, End Users and Geography  

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Renal Denervation Market Size, Share, Growth, Trends, and Global Industry Analysis: Product (EnligHTN renal denervation system, Iberis renal denervation system, Paradise renal denervation system, Symplicity renal denervation system, Vessix renal denervation system, Others), Technology (Micro infusion, Pharmacologic ablation, Radiofrequency ablation, Ultrasound ablation), End Users (Hospitals, Clinics, Ambulatory surgical centers, Others) and Region  

checked icon arrow_drop_down
checked icon Single User License $4400
checked icon Multiple User License $6600
checked icon Corporate User License $8900

1. Executive Summary
2. Global Renal Denervation Market Introduction
2.1. Global Renal Denervation Market – Taxonomy
2.2. Global Renal Denervation Market –Definitions
2.2.1. Product
2.2.2. Technology
2.2.3. End User
3. Global Renal Denervation Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Renal Denervation Market Dynamic Factors - Impact Analysis
3.6. Impact of COVID 19 on The Market
3.7. Three Forecast Scenarios - Pessimistic, Conservative and Opportunistic
3.8. Mapping Market Players Activities
3.9. Recent Key Developments
3.10. Financial Status of the Market Players
3.11. Recent Acquisitions, Collaborations and Mergers
4. Global Renal Denervation Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Renal Denervation Market, By Product, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
5.1. EnligHTN renal denervation system
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Iberis renal denervation system
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Paradise renal denervation system
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Symplicity renal denervation system
5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Vessix renal denervation system
5.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Others
5.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
6. Global Renal Denervation Market Forecast, By Technology, 2017-2021 and Forecast, 2021 – 2027 (Revenue, US$ Mn)
6.1. Micro infusion
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Pharmacologic ablation
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Radiofrequency ablation
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Ultrasound ablation
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Renal Denervation Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
7.1. Hospitals
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Clinics
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Ambulatory surgical centers
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Others
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Global Renal Denervation Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
8.1. North America
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Renal Denervation Market - Opportunity Analysis Index, By Product, Technology, End User and Region, 2022-2028
9. North America Renal Denervation MarketAnalysis,2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
9.1. By Product Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn),Y-o-Y Growth (%), and Market Share (%)
9.1.1. EnligHTN renal denervation system
9.1.2. Iberis renal denervation system
9.1.3. Paradise renal denervation system
9.1.4. Symplicity renal denervation system
9.1.5. Vessix renal denervation system
9.1.6. Others
9.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Micro infusion
9.2.2. Pharmacologic ablation
9.2.3. Radiofrequency ablation
9.2.4. Ultrasound ablation
9.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Hospitals
9.3.2. Clinics
9.3.3. Ambulatory surgical centers
9.3.4. Others
9.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. USA
9.4.2. Canada
9.5. North America Renal Denervation Market - Opportunity Analysis Index, By  Product, Technology, End User, and Country, 2022-2028
9.6. North America Renal Denervation Market Dynamics – Trends
10. Europe Renal Denervation Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
10.1. By Product Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn),Y-o-Y Growth (%), and Market Share (%)
10.1.1. EnligHTN renal denervation system
10.1.2. Iberis renal denervation system
10.1.3. Paradise renal denervation system
10.1.4. Symplicity renal denervation system
10.1.5. Vessix renal denervation system
10.1.6. Others
10.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Micro infusion
10.2.2. Pharmacologic ablation
10.2.3. Radiofrequency ablation
10.2.4. Ultrasound ablation
10.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Hospitals
10.3.2. Clinics
10.3.3. Ambulatory surgical centers
10.3.4. Others
10.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Renal Denervation Market - Opportunity Analysis Index, By  Product, Technology, End User, and Country, 2022-2028
10.6. Europe Renal Denervation Market Dynamics – Trends
11. Asia-Pacific Renal Denervation Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
11.1. By Product Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn),Y-o-Y Growth (%), and Market Share (%)
11.1.1. EnligHTN renal denervation system
11.1.2. Iberis renal denervation system
11.1.3. Paradise renal denervation system
11.1.4. Symplicity renal denervation system
11.1.5. Vessix renal denervation system
11.1.6. Others
11.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Micro infusion
11.2.2. Pharmacologic ablation
11.2.3. Radiofrequency ablation
11.2.4. Ultrasound ablation
11.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Hospitals
11.3.2. Clinics
11.3.3. Ambulatory surgical centers
11.3.4. Others
11.4. Country Analysis2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Renal Denervation Market - Opportunity Analysis Index, By  Product, Technology, End User, and Country, 2022-2028
11.6. Asia-Pacific Renal Denervation Market Dynamics – Trends
12. Latin America Renal Denervation Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
12.1. By Product Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn),Y-o-Y Growth (%), and Market Share (%)
12.1.1. EnligHTN renal denervation system
12.1.2. Iberis renal denervation system
12.1.3. Paradise renal denervation system
12.1.4. Symplicity renal denervation system
12.1.5. Vessix renal denervation system
12.1.6. Others
12.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Micro infusion
12.2.2. Pharmacologic ablation
12.2.3. Radiofrequency ablation
12.2.4. Ultrasound ablation
12.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Hospitals
12.3.2. Clinics
12.3.3. Ambulatory surgical centers
12.3.4. Others
12.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Rest of Latin America
12.5. Latin America Renal Denervation Market - Opportunity Analysis Index, By  Product, Technology, End User, and Country, 2022-2028
12.6. Latin America Renal Denervation Market Dynamics – Trends
13. Middle East and Africa Renal Denervation Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn)
13.1. By Product Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn),Y-o-Y Growth (%), and Market Share (%)
13.1.1. EnligHTN renal denervation system
13.1.2. Iberis renal denervation system
13.1.3. Paradise renal denervation system
13.1.4. Symplicity renal denervation system
13.1.5. Vessix renal denervation system
13.1.6. Others
13.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Micro infusion
13.2.2. Pharmacologic ablation
13.2.3. Radiofrequency ablation
13.2.4. Ultrasound ablation
13.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Hospitals
13.3.2. Clinics
13.3.3. Ambulatory surgical centers
13.3.4. Others
13.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Renal Denervation Market - Opportunity Analysis Index, By  Product, Technology, End User, and Country, 2022-2028
13.6. MEA Renal Denervation Market Dynamics – Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Technology& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Ablative Solutions
14.2.2. Johnson & Johnson
14.2.3. Cardiosonic Incorporated
14.2.4. Boston Scientific Corporation
14.2.5. Medtronic plc
14.2.6. Mercator MedSystems
14.2.7. ReCor Medical
14.2.8. Renal Dynamics Limited
14.2.9. Terumo corporation
14.2.10. Symple Surgical
15. Research Methodology
16. Key Assumptions and Acronyms

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

Key Market Players

  • Ablative Solutions
  • Johnson & Johnson
  • Cardiosonic Incorporated
  • Boston Scientific Corporation
  • Medtronic plc
  • Mercator MedSystems
  • ReCor Medical
  • Renal Dynamics Limited
  • Terumo corporation
  • Axonics, Inc.

Related Industry Reports

Cell Sorting Market

Brazil Rare Diseases Market

High Throughput Screening Market

Biomaterials Market